Improving the Quality of Outpatient Diabetes Care Using an Information Management System: Results From the Observational VISION Study
- PMID: 26224760
- PMCID: PMC4738206
- DOI: 10.1177/1932296815595984
Improving the Quality of Outpatient Diabetes Care Using an Information Management System: Results From the Observational VISION Study
Abstract
Background: This study aimed to evaluate the effects of information management system (IMS) use with individuals with type 1 and type 2 diabetes who were treated in outpatient settings.
Methods: In this 7-month, prospective, observational study, 965 adults with diabetes, mean (SD) baseline HbA1c 8.61(1.2)% (70.6[13.1] mmol/mol), were recruited from 132 outpatient care centers in Germany and Denmark. HbA1c was measured at baseline, month 4, and month 7. IMS reports were generated from uploaded self-monitored blood glucose data and therapy adjustments were documented at months 1 and 4. Hypoglycemic events were documented.
Results: Mean (SD) HbA1c decreased from baseline in type 1 and type 2 diabetes patients at month 4 (-0.61[1.03]% (-6.7[11.3] mmol/mol), n = 213; -0.88[1.22]% (-9.6[13.3] mmol/mol), n = 589, respectively) and month 7 (-0.64[1.02]% (-7.0[11.1] mmol/mol), n = 219; -0.93[1.27]% (-10.2[13.9] mmol/mol), n = 594, respectively), all P < .0001, with no increase in hypoglycemic events. Therapy was adjusted in 106(42.7)% type 1 and 349(52.4)% type 2 diabetes patients at months 1 and 105(42.3)% type 1 and 282(42.3)% type 2 diabetes patients at month 4. Physicians used IMS reports to make therapy adjustments in 90% of patients at month 1 and 86% of patients at month 4.
Conclusions: Integration of the IMS into outpatient care facilitates significant improvements in glycemic control.
Keywords: information management system; self-monitoring of blood glucose; type 1 diabetes; type 2 diabetes.
© 2015 Diabetes Technology Society.
Conflict of interest statement
Figures



Similar articles
-
Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.J Diabetes. 2017 May;9(5):495-501. doi: 10.1111/1753-0407.12434. Epub 2016 Aug 21. J Diabetes. 2017. PMID: 27249791 Clinical Trial.
-
Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.Diabetes Care. 2020 Sep;43(9):2153-2160. doi: 10.2337/dc20-0738. Epub 2020 Jul 15. Diabetes Care. 2020. PMID: 32669277 Free PMC article.
-
A pragmatic real-life study of flash glucose monitoring versus self-monitoring of blood glucose.Dan Med J. 2020 Jun 1;67(6):A07190404. Dan Med J. 2020. PMID: 32741434
-
The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study.Diabetes Res Clin Pract. 2022 Jan;183:109172. doi: 10.1016/j.diabres.2021.109172. Epub 2021 Dec 6. Diabetes Res Clin Pract. 2022. PMID: 34883185
-
Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial.Lancet Diabetes Endocrinol. 2020 Jan;8(1):17-26. doi: 10.1016/S2213-8587(19)30385-7. Lancet Diabetes Endocrinol. 2020. PMID: 31862147 Clinical Trial.
Cited by
-
Visualization of Patient-Generated Health Data: A Scoping Review of Dashboard Designs.Appl Clin Inform. 2023 Oct;14(5):913-922. doi: 10.1055/a-2174-7820. Epub 2023 Sep 13. Appl Clin Inform. 2023. PMID: 37704021 Free PMC article.
-
Using an mHealth approach to collect patient-generated health data for predicting adverse health outcomes among adult survivors of childhood cancer.Front Oncol. 2024 May 10;14:1374403. doi: 10.3389/fonc.2024.1374403. eCollection 2024. Front Oncol. 2024. PMID: 38800387 Free PMC article.
-
Open Ecosystem Through Secure Plug and Play Interoperability: An Overview.J Diabetes Sci Technol. 2025 May;19(3):628-641. doi: 10.1177/19322968241310253. Epub 2025 Jan 8. J Diabetes Sci Technol. 2025. PMID: 39773007 Free PMC article. Review.
-
PDM-ProValue meets cardiovascular outcome trials in diabetes.Cardiovasc Diabetol. 2019 Jan 28;18(1):10. doi: 10.1186/s12933-019-0815-3. Cardiovasc Diabetol. 2019. PMID: 30691463 Free PMC article.
-
Integrated Personalized Diabetes Management (PDM): Design of the ProValue Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients With Insulin-Treated Type 2 Diabetes.J Diabetes Sci Technol. 2016 May 3;10(3):772-81. doi: 10.1177/1932296815617487. Print 2016 May. J Diabetes Sci Technol. 2016. PMID: 26645793 Free PMC article. Clinical Trial.
References
-
- Duran A, Martin P, Runkle I, et al. Benefits of self-monitoring blood glucose in the management of new-onset type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes. 2010;2:203-211. - PubMed
-
- Franciosi M, Lucisano G, Pellegrini F, et al. ROSES: role of self-monitoring of blood glucose and intensive education in patients with type 2 diabetes not receiving insulin. A pilot randomized clinical trial. Diabet Med. 2011;28:789-796. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical